Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dexcom (DXCM) Acquisitions (2021 - 2022)

Historic Acquisitions for Dexcom (DXCM) over the last 2 years, with Q3 2022 value amounting to $700000.0.

  • Dexcom's Acquisitions fell 9778.48% to $700000.0 in Q3 2022 from the same period last year, while for Jun 2023 it was $700000.0, marking a year-over-year decrease of 9790.42%. This contributed to the annual value of $3.9 million for FY2022, which is 8708.61% down from last year.
  • Dexcom's Acquisitions amounted to $700000.0 in Q3 2022, which was down 9778.48% from $3.2 million recorded in Q1 2022.
  • In the past 5 years, Dexcom's Acquisitions ranged from a high of $31.6 million in Q3 2021 and a low of -$1.4 million during Q4 2021